Inventor · disambiguated record
Jean-Marie Contreras
Also filed as: CONTRERAS JEAN-MARIE · CONTRERAS JEAN-MARIE GEORGES
9 granted patents·8 pending applications·17 citations·filing 2003–2025
80Inventor score
Files withBIONOMICS LTD7MERCK SHARP & DOHME LLC3JANSSEN PHARMACEUTICA NV2ALTANA PHARMA AG1LACRAMPE JEAN FERAND ARMAND1
Top patents by PatentIndex Score
17 records- 0184US7834016B2Inhibitors of the interaction between MDM2 and p53JANSSEN PHARMACEUTICA NV·Filed 2005·Granted Nov 16, 2010·8 cites·36 claims
- 0275US8404683B2Inhibitors of the interaction between MDM2 and P53LACRAMPE JEAN FERAND ARMAND·Filed 2010·Granted Mar 26, 2013·6 cites·2 claims
- 0373US8377961B2Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and P53JANSSEN PHARMACEUTICA NV·Filed 2011·Granted Feb 19, 2013·2 cites·2 claims
- 0471US8088795B2Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and p53LACRAMPE JEAN FERNAND ARMAND·Filed 2007·Granted Jan 3, 2012·1 cites·6 claims
- 0570US2024262825A1Pain treating compounds and uses thereofBIONOMICS LTD·Filed 2024·Application pending·0 cites
- 0666US12275732B2Cyclic compounds as receptor modulating therapeutics and methods and uses thereofBIONOMICS LTD·Filed 2019·Granted Apr 15, 2025·0 cites·10 claims
- 0760US2025214998A1Cyclic compounds as receptor modulating therapeutics and methods and uses thereofBIONOMICS LTD·Filed 2025·Application pending·0 cites
- 0857US2024368109A1Allosteric modulators of nicotinic acetylcholine receptorsMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 0955US2025002448A1Allosteric modulators of nicotinic acetylcholine receptorsMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 1054US2021230157A1Pain treating compounds and uses thereofBIONOMICS LTD·Filed 2019·Application pending·0 cites
- 1150US12090146B2Substituted-pyridinyl compounds and uses thereofBIONOMICS LTD·Filed 2019·Granted Sep 17, 2024·0 cites·12 claims
- 1247US12331022B2Spiropiperidine allosteric modulators of nicotinic acetylcholine receptorsMERCK SHARP & DOHME LLC·Filed 2020·Granted Jun 17, 2025·0 cites·5 claims
- 1347US12139473B2Substituted-N-heteroaryl compounds and uses thereofBIONOMICS LTD·Filed 2019·Granted Nov 12, 2024·0 cites·14 claims
- 1439US2008064714A1Novel PyrrolodihydroisoquinolinesNYCOMED GMBH·Filed 2006·Application pending·0 cites
- 1538US7488755B2Derivatives of glycinergic R(+)-2-amino-3-hydroxypropanoic acidPRESTWICK PHARMACEUTICALS INC·Filed 2003·Granted Feb 10, 2009·0 cites·11 claims
- 1638US2020392126A1Isoxazolyl compounds as receptor modulating compounds and methods and uses thereofBIONOMICS LTD·Filed 2018·Application pending·0 cites
- 1738US2008161338A1Novel Pyrrolodihydroisoquinolines as Pde 10 InhibitorsALTANA PHARMA AG·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jean-Marie Contreras files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →